- Tim Cook Should Tell Congress to Kiss His Ass
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
- 5 Worst Home Renovation Projects
- How the New York Hedge Funds Lost Their Shirts on Tesla
- What You Wear to the Office Still Matters
Tesla's Elon Musk: A Financial Wizard
Tesla's DOE loan repayment speaks volumes about CEO Elon Musk's financial savvy.
Real Money Previews
Kass: Apple Is Ripe for a Buy
The risk/reward ratio has begun to move into positive territory.
Cramer: Recipe for Ringing the Register
The hottest stocks, in particular, could see some real mayhem ahead.
Kass: Are Valuations Peaking?
The market's P/E ratio appears to be stretched.
Mad Money Recap
'Mad Money' Lightning Round: I Like CVS Over Rite Aid
Cramer wants you to wait on Corning and AT&T and he's watching Oracle.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.
Stock Ideas
5 Stocks Under $10 Set to Soar
These under-$10 stocks look poised to trade higher from current levels.
5 Big Stocks That Could Drop in May
The market rally might have the fundamental and technical legs to keep climbing, but keep your finger on the 'sell' button for these five stocks.
Apple: Keep Tim Cook's Feet to the Fire
Don't associate Tim Cook's performance on Capitol Hill with his ability to innovate at Apple.
'Mad Money' Lightning Round: I Like CVS Over Rite Aid
Cramer wants you to wait on Corning and AT&T and he's watching Oracle.
Cramer's Top Stock Picks: CLH SIX WFM
Investors can clean up with Clean Harbors, have fun with Six Flags and dine out on Whole Foods, Cramer said.
Personal Finance
Taubman's Tasty Preferred Shares
The common shares of the shopping-mall owner are expensive, but its preferred shares are worth a look.
The Digital Skeptic: Eerie How Web's Future Looks Like Useless Erie Canal
Wonder of the world? Once, but it's not too early to call out the vision of a 50-million-mile Web trench to nowhere.
What That 'Check Engine' Warning Light Means
Sometimes it means a $5,474 transmission repair. But sometimes it means tightening a gas cap.
Frequent Travelers Are the Ones Wasting Rewards Points
It's mainly men letting rewards points come and go, expiring even as they travel once a week or more.
Public Almost a Year, Healthcare Trust of America Is Still a Solid Buy
The health care REIT should do well when the federal health insurance law fully kicks in.
Instant Spin
Stock Market Today
Stocks Drop in Choppy Session
Major U.S. stock averages on Thursday are holding lower in a choppy trading session.
Options Profits Previews
Who's Hedged? Seriously, Who's Hedged?
Henry Schwartz of Trade Alert analyzes the impressive million-contract-per day average volume for SPX options this month.
Developing a Relationship With Implied Volatility
CBOE's Russell Rhoads says there are two pieces of the puzzle that should help lead to the best option to buy or sell depending on your stock price forecast.
XLF Mega Bear Spreads
In the options market, hefty spreads on the XLF have been noteworthy and seem to be expressing concerns about a possible pullback in months ahead.
Biotech Stocks
Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE)
Two charts show how investors feel differently about Keryx and Acadia Pharma.
Rockwell Medical Run-Up Trade Follows Financing
One trader believes Rockwell shares will rise into clinical trial results expected in July.
2013 FDA Drug Approval Calendar
An updated list of the biotech and drug firms expecting FDA drug approval decisions in 2013.
Deal News
Tesla's Elon Musk: A Financial Wizard
Tesla's DOE loan repayment speaks volumes about CEO Elon Musk's financial savvy.
Apax Partners Retreads Rue21 Amid Retail Buyout Boom
Rue21 has agreed to its second buyout by private equity firm Apax Partners.
Bloomberg's 'Spygate' Marks Murdoch's Latest Salvo
The New York Post has played pitbull as News Corp. attempts to chip away at Bloomberg's profitable analytics business.
TheStreetTV
Spin Space
Jim Cramer
Why Whole Foods Is Hot
Jim Cramer looks at why Whole Foods remains well positioned to continue to surge, with 'Mad Money' Research Director Nicole Urken
James Rogers
Investors Warm to HP but Big Challenges Remain
Investors may have been warming to HP ahead of its second-quarter results, but there are plenty of hurdles in CEO Meg Whitman's path.
Chris Ciaccia
HP Pops on Earnings Beat
HP's first-quarter earnings beat Wall Street expectations, sending the stock soaring in after-hours.
Laurie Kulikowski
Children's Place Spikes as Guidance Is Raised
Children's Place spikes Thursday after the children's apparel retailer lifts its fiscal-year guidance despite disappointing earnings results.
Philip van Doorn
Immelt Pushes Harder to Shrink GE Capital
General Electric CEO Jeff Immelt on Tuesday reiterated the firm's plan to keep shrinking its finance arm, hinting at possible spinoffs.
Dan Freed
Starwood Upgraded as Capital Return Eyed
Hotelier seen sitting on $7 in excess capital that could be returned to shareholders.
Adam Feuerstein
Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE)
Two charts show how investors feel differently about Keryx and Acadia Pharma.
Ted Reed
Chrysler to Tesla: Not So Fast on Payback Claim
Tesla says it's the only U.S. automaker to repay its federal loans, but Chrysler paid back its loans in 2011.
Rocco Pendola
Apple: Keep Tim Cook's Feet to the Fire
Don't associate Tim Cook's performance on Capitol Hill with his ability to innovate at Apple.
Anton Wahlman
Electric Cars: The Right and Wrong Reasons for Buying
When all is said and done, it's all about the actual driving experience.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
|
|
Brokerage Partners
|
|
|
|
|
|
|
|
Most Commented
Advertising Partners
|
|
Special Features